These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Policy must recognize drug impact on different sectors. Pierce R; Illes J Nature; 2008 Jan; 451(7178):521. PubMed ID: 18235479 [No Abstract] [Full Text] [Related]
4. Ethics of mental enhancement: do adults taking ADHD medication have an unfair advantage? Thomas JD Mod Healthc; 2013 Jul; 43(27):27. PubMed ID: 23878921 [No Abstract] [Full Text] [Related]
5. Rationality is a better basis for ethics than repugnance. Farah MJ Nature; 2008 Jan; 451(7178):521. PubMed ID: 18235478 [No Abstract] [Full Text] [Related]
6. Neuroenhancers, addiction and research ethics. Shaw DM J Med Ethics; 2012 Oct; 38(10):605-8. PubMed ID: 22888151 [TBL] [Abstract][Full Text] [Related]
7. Accelerating human evolution. Harris ED Pharos Alpha Omega Alpha Honor Med Soc; 2009; 72(3):1. PubMed ID: 19722297 [No Abstract] [Full Text] [Related]
8. The action of enhancers can lead to addiction. Volkow ND; Swanson JM Nature; 2008 Jan; 451(7178):520. PubMed ID: 18235477 [No Abstract] [Full Text] [Related]
9. ["Cognitive doping": meaning and stakes]. De Pauw E J Int Bioethique; 2011; 22(3-4):79-92, 195-6. PubMed ID: 22238909 [TBL] [Abstract][Full Text] [Related]
10. Much ado about cognitive enhancement. Oliveira JR Nature; 2009 Jan; 457(7229):532. PubMed ID: 19177105 [No Abstract] [Full Text] [Related]
11. Ethical issues in the use of cognitive enhancement. Darby R Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376 [No Abstract] [Full Text] [Related]
12. Cosmetic neurology: Sliding down the slippery slope? Launis V Camb Q Healthc Ethics; 2010 Apr; 19(2):218-29. PubMed ID: 20226105 [No Abstract] [Full Text] [Related]
14. Enhancements, easy shortcuts, and the richness of human activities. Schermer M Bioethics; 2008 Aug; 22(7):355-63. PubMed ID: 18445089 [TBL] [Abstract][Full Text] [Related]
16. Brain gain: the underground world of neuroenhancing drugs. Talbot M New Yorker; 2009 Apr; ():32-43. PubMed ID: 19399986 [No Abstract] [Full Text] [Related]
17. Justice, fairness, and enhancement. Savulescu J Ann N Y Acad Sci; 2006 Dec; 1093():321-38. PubMed ID: 17312266 [TBL] [Abstract][Full Text] [Related]
18. Straining their brains: why the case against enhancement is not persuasive. Caplan AL Cerebrum; 2004; 6(4):14-8. PubMed ID: 15986529 [No Abstract] [Full Text] [Related]
19. The turn for ultimate harm: a reply to Fenton. Persson I; Savulescu J J Med Ethics; 2011 Jul; 37(7):441-4. PubMed ID: 21343630 [TBL] [Abstract][Full Text] [Related]
20. How does enhancing cognition affect human values? How does this translate into social responsibility? Cabrera LY Curr Top Behav Neurosci; 2015; 19():223-41. PubMed ID: 25048389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]